ONO Pharmaceutical logo

ONO Pharmaceutical

North America, Massachusetts, United States, Cambridge

Description

ONO Pharmaceutical is focused on the production, purchase, and sale of pharmaceuticals and diagnostic reagents.

Investor Profile

ONO Pharmaceutical has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (100%)

Country Focus

  • Japan (100%)

Industry Focus

  • Elder Care
  • Health Care
  • Rehabilitation
  • Saas
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does ONO Pharmaceutical frequently co-invest with?

SMBC Venture Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Capital Medica Ventures
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Global Brain Corporation
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Cyberdyne
Asia, Ibaraki, Japan, Tsukuba
Co-Investments: 1
Toyoshima
Asia, Aichi, Japan, Nagoya
Co-Investments: 1
MV
Asia, Aichi, Japan, Nagoya
Co-Investments: 1
Mitsubishi UFJ Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Kirin Holdings
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1

What are some of recent deals done by ONO Pharmaceutical?

Rehab

Tokyo, Tokyo, Japan

Rehab develops a rehabilitation support SaaS "Rehaplan" for adult day care centers.

Elder CareHealth CareRehabilitationSaaSSoftware
Series BMay 24, 2021
Amount Raised: $6,430,691